Modulation of Gut Microbiota by Traditional Chinese Medicine (TCM): A Novel Strategy for the Treatment of Metabolic Diseases
DOI:
https://doi.org/10.61173/pyyksq31Keywords:
gut microbiota, metabolic diseases, traditional Chinese medicine, obesity, diabetesAbstract
Globally, metabolic diseases are highly prevalent, which not only compromise patients’ quality of life but also impose a heavy socioeconomic burden on society. Moreover, gut microbiota dysbiosis is one of the key components in the progression of these diseases. This review focuses on the treatment of metabolic diseases through the modulation of gut microbiota by Traditional Chinese Medicine (TCM). It aims to clarify the mechanisms by which TCM improves metabolic diseases via regulating gut microbiota, as well as the interaction between TCM and gut microbiota. Additionally, this review summarizes the research evidence of TCM in treating certain metabolic diseases and outlines future research.
References
tion model of „TCM-gut microbiota-host“ and its related [1] Fan, Y., & Pedersen, O. (2021). Gut microbiota in mechanisms, providing new perspectives and a theoretical human metabolic health and disease. Nature reviews. basis for the clinical intervention of metabolic diseases. Microbiology, 19(1), 55–71. https://doi.org/10.1038/s41579- Regarding the bidirectional interaction between TCM and 020-0433-9
gut microbiota, this review analyzes and points out that [2] Agus, A., Clément, K., & Sokol, H. (2021). Gut microbiotathere is a close bidirectional regulation between the two: derived metabolites as central regulators in metabolic TCM can regulate the gut microbiota through their bioac- disorders. Gut, 70(6), 1174–1182. https://doi.org/10.1136/ tive components, while the gut microbiota can transform gutjnl-2020-323071 TCM components through reactions such as enzymatic [3] Jaacks, L. M., Vandevijvere, S., Pan, A., McGowan, C. J., hydrolysis, thereby enhancing the bioavailability of TCM Wallace, C., Imamura, F., Mozaffarian, D., Swinburn, B., &
or reducing their toxicity. Ezzati, M. (2019). The obesity transition: stages of the global In terms of the core mechanisms, this review discusses epidemic. The lancet. Diabetes & endocrinology, 7(3), 231–240. five key pathways: 1) protecting intestinal barrier integ- https://doi.org/10.1016/S2213-8587(19)30026-9 rity; 2) improving metabolic endotoxemia and inflamma- [4] Schumann, T., König, J., Henke, C., Willmes, D. M., tion; 3) mediating systemic regulation via metabolites; 4) Bornstein, S. R., Jordan, J., Fromm, M. F., & Birkenfeld, A.
regulating neuroendocrine function through the gut-brain L. (2020). Solute Carrier Transporters as Potential Targets axis to inhibit appetite or improve energy balance; and 5) for the Treatment of Metabolic Disease. Pharmacological modulating the immunometabolic network. reviews, 72(1), 343–379. https://doi.org/10.1124/pr.118.015735
Regarding the research status of TCM in treating spe- [5] Feng, W., Ao, H., Peng, C., & Yan, D. (2019). Gut cific metabolic diseases, this review sorts out abundant microbiota, a new frontier to understand traditional Chinese research evidence on several types of metabolic diseases. medicines. Pharmacological research, 142, 176–191. https://doi. All these studies confirm that TCM can provide safe and org/10.1016/j.phrs.2019.02.024 effective therapeutic strategies for metabolic diseases by [6] Zhou W.J., Yang W.R., Liu X.F., Xu X.R., Fan X &X Y.L.
reshaping gut microbiota structure, regulating microbiota (2025). Research progress of interaction between traditional metabolites, and modulating related signaling pathways. Chinese medicine and intestinal flora in disease treatment. However, the research in this review still has limitations. Chinese Herbal Medicine, 56(11),4080-4089. The number of studies included in this review is limited, [7] Yue, S. J., Wang, W. X., Yu, J. G., Chen, Y. Y., Shi, X. and clinical evidence in humans is weak. Currently, most Q., Yan, D., Zhou, G. S., Zhang, L., Wang, C. Y., Duan, J.
A., & Tang, Y. P. (2019). Gut microbiota modulation with Dean&Francis ISSN 2959-409X traditional Chinese medicine: A system biology-driven mellitus through modulating the gut microbiota and bile approach. Pharmacological research, 148, 104453. https://doi. acids metabolism. Phytomedicine : international journal of org/10.1016/j.phrs.2019.104453 phytotherapy and phytopharmacology, 113, 154733. https://doi. [8] Zhang, H. Y., Tian, J. X., Lian, F. M., Li, M., Liu, W. org/10.1016/j.phymed.2023.154733
K., Zhen, Z., Liao, J. Q., & Tong, X. L. (2021). Therapeutic [15] Gao, K., Yang, R., Zhang, J., Wang, Z., Jia, C., Zhang, F., mechanisms of traditional Chinese medicine to improve Li, S., Wang, J., Murtaza, G., Xie, H., Zhao, H., Wang, W., &
metabolic diseases via the gut microbiota. Biomedicine & Chen, J. (2018). Effects of Qijian mixture on type 2 diabetes pharmacotherapy = Biomedecine & pharmacotherapie, 133, assessed by metabonomics, gut microbiota and network 110857. https://doi.org/10.1016/j.biopha.2020.110857 pharmacology. Pharmacological research, 130, 93–109. https:// [9] Zhong, L. J., Xie, Z. S., Yang, H., Li, P., & Xu, X. J. (2017). doi.org/10.1016/j.phrs.2018.01.011
Moutan Cortex and Paeoniae Radix Rubra reverse high-fat- [16] Nie, Q., Chen, H., Hu, J., Fan, S., & Nie, S. (2019). Dietary diet-induced metabolic disorder and restore gut microbiota compounds and traditional Chinese medicine ameliorate type 2 homeostasis. Chinese journal of natural medicines, 15(3), 210– diabetes by modulating gut microbiota. Critical reviews in food 219. https://doi.org/10.1016/S1875-5364(17)30037-7 science and nutrition, 59(6), 848–863. https://doi.org/10.1080/10 [10] Espín, J. C., González-Barrio, R., Cerdá, B., López-Bote, 408398.2018.1536646
C., Rey, A. I., & Tomás-Barberán, F. A. (2007). Iberian pig [17] European Association for the Study of the Liver (EASL), as a model to clarify obscure points in the bioavailability and European Association for the Study of Diabetes (EASD), metabolism of ellagitannins in humans. Journal of agricultural & European Association for the Study of Obesity (EASO)
and food chemistry, 55(25), 10476–10485. https://doi. (2016). EASL-EASD-EASO Clinical Practice Guidelines for org/10.1021/jf0723864 the management of non-alcoholic fatty liver disease. Journal [11] Feng, W., Liu, J., Huang, L., Tan, Y., & Peng, C. (2021). of hepatology, 64(6), 1388–1402. https://doi.org/10.1016/ Gut microbiota as a target to limit toxic effects of traditional j.jhep.2015.11.004 Chinese medicine: Implications for therapy. Biomedicine & [18] Clayton-Chubb, D., Kemp, W., Majeed, A., Lubel, J. S.,
pharmacotherapy = Biomedecine & pharmacotherapie, 133, Hodge, A., & Roberts, S. K. (2023). Understanding NAFLD: 111047. https://doi.org/10.1016/j.biopha.2020.111047 From Case Identification to Interventions, Outcomes, and Future [12] Zhang, Q., Bai, Y., Wang, W., Li, J., Zhang, L., Tang, Perspectives. Nutrients, 15(3), 687. https://doi.org/10.3390/
Y., & Yue, S. (2023). Role of herbal medicine and gut nu15030687 microbiota in the prevention and treatment of obesity. Journal [19] Zhu, L. R., Li, S. S., Zheng, W. Q., Ni, W. J., Cai, M., &
of ethnopharmacology, 305, 116127. https://doi.org/10.1016/ Liu, H. P. (2023). Targeted modulation of gut microbiota by j.jep.2022.116127 traditional Chinese medicine and natural products for liver [13] Wang, Z., Wang, X., Fu, L., Xu, S., Wang, X., Liao, Q., disease therapy. Frontiers in immunology, 14, 1086078. https:// Zhuang, T., Liu, L., Zhang, H., Li, W., Xiong, A., Gu, L., Wang, doi.org/10.3389/fimmu.2023.1086078
Z., Wang, R., Tao, F., Yang, L., & Ding, L. (2024). Shengmai San [20] Du Y.S., Luo L, Han B.W., Qin H.J., Lu Y.N., & D. Z.Q.
formula alleviates high-fat diet-induced obesity in mice through (2025). Based on the “gut-microflora-liver” axis, this paper gut microbiota-derived bile acid promotion of M2 macrophage discusses the research progress of traditional Chinese medicine polarization and thermogenesis. Phytomedicine : international in regulating intestinal flora to treat nonalcoholic fatty liver journal of phytotherapy and phytopharmacology, 133, 155938. disease. Shaanxi Traditional Chinese Medicine, 46(06),857-860. https://doi.org/10.1016/j.phymed.2024.155938 [21] Tahir, U. A., & Gerszten, R. E. (2023). Molecular [14] Tawulie, D., Jin, L., Shang, X., Li, Y., Sun, L., Xie, Biomarkers for Cardiometabolic Disease: Risk Assessment in
H., Zhao, J., Liao, J., Zhu, Z., Cui, H., & Wen, W. (2023). Young Individuals. Circulation research, 132(12), 1663–1673. Jiang-Tang-San-Huang pill alleviates type 2 diabetes https://doi.org/10.1161/CIRCRESAHA.123.322000 Dean&Francis Linglonghua Zhang [22] Chen, X., Zhang, H., Ren, S., Ding, Y., Remex, N. S., fendo.2024.1366285
Bhuiyan, M. S., Qu, J., & Tang, X. (2023). Gut microbiota [24] Cui, H., Han, S., Dai, Y., Xie, W., Zheng, R., Sun, and microbiota-derived metabolites in cardiovascular Y., Xia, X., Deng, X., Cao, Y., Zhang, M., & Shang, H.
diseases. Chinese medical journal, 136(19), 2269–2284. https:// (2023). Gut microbiota and integrative traditional Chinese doi.org/10.1097/CM9.0000000000002206 and western medicine in prevention and treatment of heart [23] Dai, J., Qiu, L., Lu, Y., & Li, M. (2024). Recent advances failure. Phytomedicine : international journal of phytotherapy of traditional Chinese medicine against cardiovascular and phytopharmacology, 117, 154885. https://doi.org/10.1016/ disease: overview and potential mechanisms. Frontiers j.phymed.2023.154885 in endocrinology, 15, 1366285. https://doi.org/10.3389/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
